PER LIVER CANCER TUMOR BOARD: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today, and Tomorrow?

Introduction, Opening Remarks, Program Overview

Improving Outcomes in HCC: A Focus on Diagnosis, Equitable Care and Unmet Needs

Tumor Board #1: Optimizing the Management of Early-stage HCC

Tumor Board #2: Treatment Approaches for Intermediate-stage HCC (iHCC)

Tumor Board #3: Managing Newly Diagnosed Advanced HCC

Tumor Board #4: Selecting Between Second-Line and Subsequent Options for Progressive Advanced/Metastatic HCC

What's Next for HCC

Question & Answer Session & Concluding Remarks